Comparison
A53 Diffuse Large B Cell Lymphoma C5707085 vs 3 5 Toe Syndactyly C4023723
Clinical comparison between A53 Diffuse Large B Cell Lymphoma and 3 5 Toe Syndactyly for differential diagnosis and treatment planning.
A53 Diffuse Large B Cell Lymphoma C5707085
An aggressive cancer of the immune system affecting infection-fighting white blood cells called B-cells. Treatment typically involves chemotherapy and may include targeted therapies.
3 5 Toe Syndactyly C4023723
A condition where the 3rd, 4th, and 5th toes are fused together, usually present from birth. It may affect walking or balance. Treatment involves surgery to separate the toes if it causes functional problems.
6 comparison axes
Onset
A53 Diffuse Large B Cell Lymphoma C5707085
50-80
3 5 Toe Syndactyly C4023723
0-0
Onset patterns differ
Severity
A53 Diffuse Large B Cell Lymphoma C5707085
severe
3 5 Toe Syndactyly C4023723
mild
Different severity levels
Chronic
A53 Diffuse Large B Cell Lymphoma C5707085
Chronic
3 5 Toe Syndactyly C4023723
Chronic
Differing course
Communicable
A53 Diffuse Large B Cell Lymphoma C5707085
No
3 5 Toe Syndactyly C4023723
No
Different transmission
Body System
A53 Diffuse Large B Cell Lymphoma C5707085
oncologic
3 5 Toe Syndactyly C4023723
musculoskeletal
Same/different system
Category
A53 Diffuse Large B Cell Lymphoma C5707085
oncology
3 5 Toe Syndactyly C4023723
genetic
Different category
Bottom line
a53-diffuse-large-b-cell-lymphoma-C5707085 and 3-5-toe-syndactyly-C4023723 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | A53 Diffuse Large B Cell Lymphoma C5707085 | 3 5 Toe Syndactyly C4023723 | Discriminating power |
|---|---|---|---|
| Onset and age | Usually recognized in adulthood, often ages 50–80, rather than at birth. | Present from birth as fused third, fourth, and fifth toes. | High |
| Systemic features | May involve rapidly enlarging nodes or masses and systemic illness; exact symptoms vary. | Localized toe fusion without immune-system disease. | High |
| Function | Can cause severe illness requiring urgent oncology assessment. | Usually mild; walking or balance may be affected in some people. | Moderate |
When to favor each condition
Choose A53 Diffuse Large B Cell Lymphoma C5707085 when
New rapidly enlarging lymph node or mass
This pattern fits an aggressive lymphoma better than a congenital toe anomaly.
High
Unexplained systemic illness in an adult
Persistent fever, night sweats, or weight loss warrant clinician evaluation; they do not diagnose lymphoma alone.
Moderate
Abnormal lymphoid tissue on biopsy
Tissue diagnosis, not appearance or a blood result alone, establishes lymphoma.
High
Choose 3 5 Toe Syndactyly C4023723 when
Toe webbing noticed at birth
Fusion of the third through fifth toes is a congenital musculoskeletal finding.
High
Stable toe appearance without systemic illness
A chronic localized anomaly is inconsistent with aggressive lymphoma.
High
Walking or footwear difficulty from fused toes
Functional problems support assessment for possible surgical separation.
Moderate
How key tests differ
| Test | A53 Diffuse Large B Cell Lymphoma C5707085 | 3 5 Toe Syndactyly C4023723 | Interpretation |
|---|---|---|---|
| Tissue biopsy | May show malignant large B cells when lymphoma is sampled. | Not used to identify toe fusion. | Biopsy can diagnose lymphoma; a result must be interpreted by specialists. |
| Physical examination and imaging of the foot | Not diagnostic of lymphoma. | Shows congenital soft-tissue or bony fusion of specified toes. | Examination distinguishes a visible anomaly from systemic cancer. |
| Staging studies | May assess disease extent after lymphoma is diagnosed. | Not routinely required for isolated syndactyly. | Staging applies to cancer, not a congenital toe finding. |
Prognosis comparison
A53 Diffuse Large B Cell Lymphoma C5707085
- Outcome
- Potentially serious but variable; some patients respond to modern therapy. Exact survival is not established here.
- Factors
- Stage, site, fitness, and treatment response influence outcome.
3 5 Toe Syndactyly C4023723
- Outcome
- Generally a stable congenital anomaly with mild severity.
- Factors
- Extent of fusion and any walking or balance limitation matter.
Time frame: Lymphoma needs timely treatment; syndactyly is lifelong unless surgically changed.
Individual prognosis requires clinician review and should not be inferred from this comparison.
Complications comparison
| Complication | Presentation |
|---|---|
| Disease progression | Can progress rapidly without appropriate cancer treatment. The fusion itself is structural and does not behave like cancer. Urgency differs markedly; exact outcomes vary. |
| Treatment effects | Chemotherapy or targeted therapy may cause significant adverse effects. Surgery, if chosen, carries procedure-specific risks. Treatment choice and doses require clinicians; none are specified here. |
| Function | Illness and treatment may broadly limit activity. Possible walking, balance, or footwear difficulty. Impact ranges from minimal to functionally important. |
Patient education highlights
- HighDifferent conditions
Lymphoma is a cancer of B cells; toe syndactyly is congenital toe fusion. One does not indicate the other.
- HighWhen to seek care
Rapidly growing masses, persistent systemic symptoms, or biopsy abnormalities need prompt clinical assessment.
- MediumToe care
Discuss surgery only if fusion causes functional or footwear problems; many cases remain mild.